CLDN4 and pancreatic neoplasm: Doxorubicin (Dox)-loaded, CPE17-conjugated liposomes (D@C-LPs) showed extensive accumulation in targeted pancreatic tumor tissues through the enhanced permeability and retention (EPR) effect and targeting of superficially exposed CLDN4 in pancreatic cancer, made accessible by disruption of tight junctions.